mutation
→
HasSubevent
→
cancer
|
0.63
|
|
mutation
→
HasSubevent
→
amino acid substitutions
|
0.57
|
|
mutation
→
HasSubevent
→
amino acid changes
|
0.55
|
|
mutation
→
HasSubevent
→
cancer development
|
0.53
|
|
mutation
→
HasSubevent
→
evolution
|
0.53
|
|
mutation
→
HasSubevent
→
a premature stop codon
|
0.51
|
|
mutation
→
HasSubevent
→
increase
|
0.51
|
|
mutation
→
HasSubevent
→
shift
|
0.50
|
|
mutation
→
HasSubevent
→
premature stop
|
0.50
|
|
mutation
→
HasSubevent
→
genomic instability
|
0.49
|
|
mutation
→
HasSubevent
→
truncated protein
|
0.48
|
|
mutation
→
HasSubevent
→
altered molecular function
|
0.45
|
|
mutation
→
HasSubevent
→
failure
|
0.41
|
|
mutation
→
HasSubevent
→
muscle weakness
|
0.41
|
|
mutation
→
HasSubevent
→
significant reduction
|
0.40
|
|
mutation
→
HasSubevent
→
misfolding
|
0.40
|
|
mutation
→
HasSubevent
→
variation
|
0.39
|
|
mutation
→
HasSubevent
→
different phenotypes
|
0.39
|
|
mutation
→
HasSubevent
→
protein
|
0.39
|
|
mutation
→
HasSubevent
→
mutant
|
0.38
|
|
mutation
→
HasSubevent
→
neurodegeneration
|
0.36
|
|
mutation
→
HasSubevent
→
sickle cell anemia
|
0.35
|
|
mutation
→
HasSubevent
→
elongated fruit
|
0.35
|
|
mutation
→
HasSubevent
→
mitochondrial dysfunction
|
0.34
|
|
mutation
→
HasSubevent
→
short protein
|
0.33
|
|
mutation
→
HasSubevent
→
life
|
0.32
|
|
mutation
→
HasSubevent
→
a high cell division rate
|
0.32
|
|
mutation
→
HasSubevent
→
constitutive activation
|
0.32
|
|
mutation
→
HasSubevent
→
truncation
|
0.32
|
|
mutation
→
HasSubevent
→
an in-frame deletion
|
0.31
|
|
mutation
→
HasSubevent
→
beneficial changes
|
0.31
|
|
mutation
→
HasSubevent
→
dramatic increase
|
0.31
|
|
mutation
→
HasSubevent
→
enzyme
|
0.31
|
|
mutation
→
HasSubevent
→
frame-shifts
|
0.31
|
|
mutation
→
HasSubevent
→
male infertility
|
0.31
|
|
mutation
→
HasSubevent
→
uncontrolled cell growth
|
0.30
|
|
mutation
→
HasSubevent
→
homeotic transformations
|
0.28
|
|
mutation
→
HasSubevent
→
the inactivation of mc synthesis
|
0.28
|
|
mutation
→
HasSubevent
→
broad-spectrum resistance
|
0.27
|
|
mutation
→
HasSubevent
→
the evolution of biodiversity
|
0.27
|
|
mutation
→
HasSubevent
→
the loss of tda production
|
0.27
|
|
mutation
→
HasSubevent
→
vision loss
|
0.26
|
|
mutation
→
HasSubevent
→
a gain of function
|
0.25
|
|
mutation
→
HasSubevent
→
an amino acid exchange
|
0.25
|
|
mutation
→
HasSubevent
→
block
|
0.25
|
|
mutation
→
HasSubevent
→
chromosomal instability
|
0.25
|
|
mutation
→
HasSubevent
→
complete loss of activity
|
0.25
|
|
mutation
→
HasSubevent
→
gene inactivation
|
0.25
|
|
mutation
→
HasSubevent
→
hyper-igm immunodeficiency synd…
|
0.25
|
|
mutation
→
HasSubevent
→
overexpression
|
0.25
|
|
mutation
→
HasSubevent
→
premature termination
|
0.25
|
|
mutation
→
HasSubevent
→
short telomeres
|
0.25
|
|
mutation
→
HasSubevent
→
thrombocytopenia
|
0.25
|
|
mutation
→
HasSubevent
→
xp
|
0.25
|
|
mutation
→
HasSubevent
→
deficiency
|
0.25
|
|
mutation
→
HasSubevent
→
the death of motor neurons
|
0.25
|
|
mutation
→
HasSubevent
→
case
|
0.24
|
|
mutation
→
HasSubevent
→
inability
|
0.24
|
|
mutation
→
HasSubevent
→
birth defects
|
0.22
|
|
mutation
→
HasSubevent
→
blindness
|
0.22
|
|
mutation
→
HasSubevent
→
anemia
|
0.21
|
|
mutation
→
HasSubevent
→
insulin resistance
|
0.19
|
|
mutation
→
HasSubevent
→
new versions of proteins
|
0.19
|
|
mutation
→
HasSubevent
→
aberrant signaling
|
0.16
|
|
mutation
→
HasSubevent
→
autoimmune disease
|
0.16
|
|
mutation
→
HasSubevent
→
constitutive kinase activation
|
0.16
|
|
mutation
→
HasSubevent
→
distinctive facial features
|
0.16
|
|
mutation
→
HasSubevent
→
excess production
|
0.16
|
|
mutation
→
HasSubevent
→
glaucoma
|
0.16
|
|
mutation
→
HasSubevent
→
intestinal polyps
|
0.16
|
|
mutation
→
HasSubevent
→
leukaemia
|
0.16
|
|
mutation
→
HasSubevent
→
misshapen head
|
0.16
|
|
mutation
→
HasSubevent
→
motor neuron degeneration
|
0.16
|
|
mutation
→
HasSubevent
→
short stature
|
0.16
|
|
mutation
→
HasSubevent
→
the insertion of one nucleotide
|
0.16
|
|